Diego Moriconi
Overview
Explore the profile of Diego Moriconi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moriconi D, Nannipieri M, Armenia S, Solini A, Bruno R
Eur J Clin Invest
. 2025 Mar;
:e70026.
PMID: 40066876
Background: Obesity is a critical risk factor for chronic kidney disease and cardiovascular disease. The study aimed to explore the relationship between endothelial function, assessed by flow-mediated dilation (FMD), and...
2.
Petralli G, Zoppo A, Rovera C, Raggi F, Salvati A, Moriconi D, et al.
Acta Diabetol
. 2025 Feb;
PMID: 39954057
Aim: Semaglutide exerts metabolic effects and cardiovascular protection in type 2 diabetes (T2D), also acting on hepatic steatosis and inflammation. No data are, so far, available on the effect of...
3.
Moriconi D, Nannipieri M, Badhwar S, Taddei S, Boutouyrie P, Bruno R
J Hypertens
. 2025 Feb;
43(4):673-680.
PMID: 39927753
Background: Arterial stiffness is a key cardiovascular risk factor influenced by conditions like hypertension, obesity and kidney function. Although large arteries have been extensively studied, small conduit arteries remain less...
4.
Trico D, Sacchetta L, Rebelos E, Cimbalo N, Chiriaco M, Moriconi D, et al.
Diabetologia
. 2024 Nov;
68(2):444-459.
PMID: 39611961
Aims/hypothesis: Postprandial hypoglycaemia (PPHG) is a frequent late complication of Roux-en-Y gastric bypass (RYGB) in people without diabetes. We aimed to examine the pathogenetic mechanisms of PPHG and its clinical...
5.
Moriconi D, Pucci L, Longo V, Antonioli L, Bellini R, Trico D, et al.
Obes Res Clin Pract
. 2024 Nov;
18(5):350-356.
PMID: 39550318
Introduction: post-bariatric hypoglycemia (PBH) is considered a chronic complication after gastric bypass (RYGB) impacting roughly 30 % of patients. Current treatments often focus on nutritional interventions to reduce the frequency...
6.
Nesti L, Chiriaco M, Sacchetta L, Moriconi D, Santoni L, Pugliese N, et al.
Eur J Prev Cardiol
. 2024 Sep;
PMID: 39325931
Background: Circadian heart rate (HR) fluctuations are associated with cardiovascular health. We examined their relationship with microvascular disease and long-term survival in patients with diabetes. Methods: In this secondary analysis...
7.
Moriconi D, Manca L, Rebelos E, Guidotti E, Bonvicini L, Troilo A, et al.
Am J Surg
. 2024 Apr;
234:143-149.
PMID: 38679511
Background: bariatric surgery stands as an effective intervention for weight loss and improved metabolic control in obesity, although over time there is a proportion of weight regain and type-2-diabetes (T2D)...
8.
Moriconi D, Nannipieri M, Armenia S, Taddei S, Solini A, Bruno R
Obes Res Clin Pract
. 2023 Oct;
17(6):485-491.
PMID: 37872043
Introduction: Obesity is a well-established risk factor for kidney disease, and tubular damage can play a pivotal role in the development of obesity-related kidney damage. This study aimed to investigate...
9.
Moriconi D, Mengozzi A, Duranti E, Cappelli F, Taddei S, Nannipieri M, et al.
J Hypertens
. 2023 Apr;
41(7):1092-1099.
PMID: 37071436
Background: Renal hemodynamics is impaired since the early stage of cardiometabolic disease. However, in obesity, its noninvasive ultrasound assessment still fails to provide pathophysiologic and clinical meaningfulness. We aimed to...
10.
Moriconi D, DAlessandro C, Giannese D, Panichi V, Cupisti A
Metabolites
. 2023 Feb;
13(2).
PMID: 36837815
Background: data regarding the association between obesity and morbidity/mortality in patients with chronic kidney disease (CKD) are uncertain and sometimes contradictory. The aims of our study were to determine the...